Solana spot ETFs saw $6.8 million in inflows as BSOL and GSOL outperformed Bitcoin and Ethereum ETFs.Solana spot ETFs saw $6.8 million in inflows as BSOL and GSOL outperformed Bitcoin and Ethereum ETFs.

BSOL and GSOL lead $6.8M inflow day as Solana spot ETFs outperform BTC and ETH ETFs

On November 10, Solana spot ETFs saw net inflows of $6.78 million, extending their winning run. In contrast, Ethereum spot ETFs experienced no inflows, and U.S. Bitcoin spot ETFs saw only $1.15 million in inflows from Bitwise’s BiBIT.

According to SoSoValue, the current increase was caused by a major one-day net inflow into Solana ETFs. Grayscale’s GSOL contributed $854,480 to the total inflows, while Bitwise’s BSOL led with $5.92 million in total inflows.

Bitwise’s $BSOL draws massive inflows despite SOL drop

Hunter Horsley, CEO of Bitwise, stated that BSOL gained popularity in just eight days after its launch on October 28, 2025. Above all, funds of more than $545 million were injected, including $30 million in a single day.

Over the same period, the nine Ethereum ETFs have experienced net withdrawals of $579 million, while the 11 spot Bitcoin ETFs have lost over $2.1 billion in assets.

Horsley emphasized that the $BSOL fund is designed to provide investors with an excellent and affordable way to gain exposure to Solana. He added that all assets are 100% staked.

In a month where Solana price dropped 29%, capital continued to flow in. The price of SOL is currently $167.85, which is significantly lower than its recent highs. Despite this, funds continue to perceive an opportunity with over 3.2 million active wallets. Additionally, SOL had around 70 million transactions processed daily in October.

Senior Analyst Sumit Roy commented that the Solan ETFs’ inflows made sense given the token’s enormous $90 billion market value. He claimed that SOL has a committed fan base, possibly the most devoted after Ethereum and Bitcoin.

Roy argued that it wouldn’t be surprising to see Solana spot ETFs make up at least 5% of that market capitalization. He claimed that $500 million is still tiny in that regard. Roy said that BSOL was undoubtedly more appealing because it started with a 100% stake.

Grayscale fee cuts spark institutional interest in SOL

On November 6, Cryptopolitan reported that Grayscale has decided to drop management fees for its Solana Trust ETF in an effort to increase adoption.  The asset management firm is placing large bets on SOL in an effort to draw in new investors.

According to SoSoValue, the investment firm stated that it will stake all of its SOL holdings at an average of 7% gross staking reward. 

Grayscale stated that it will drop management fees on its Solana Trust ETF for up to three months, or until the fund has $1 billion in assets under management, whichever comes first. According to Grayscale, the change will allocate a larger portion of the financial gains to investors in an effort to attract additional funding.

Solana continues to garner major institutional interest as traditional financial organizations disclose exposure to Solana spot ETFs. 

According to a U.S. SEC filings report, Rothschild Investment LLC and PNC Financial Services have revealed stakes in Solana-linked ETFs, showing rising trust in the network. 

The US SEC filings reveal that Rothschild Investment LLC, which manages over $1.5 billion in assets, holds 6,000 shares of the Volatility Shares Solana ETF (SOLZ), valued at about $132,720. According to the report, PNC Financial Services also revealed similar stances, showing the growing participation of traditional banking firms in Solana ETFs.

Claim your free seat in an exclusive crypto trading community - limited to 1,000 members.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$95,305.08
$95,305.08$95,305.08
-1.52%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23